Myriad Launches AI Prostate Cancer Test
Myriad Genetics introduces Prolaris + AI for prostate cancer diagnosis, potentially improving treatment outcomes. This may impact healthcare stocks.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.